HbA1c Testing Market is expected to register a CAGR of 12.9% to reach USD 3229.3 Million by the end of forecast period
The HbA1c Testing Market is projected to reach USD 3229.3 Million by 2030 at 12.9% CAGR during the forecast period 2022-2030. Hemoglobin A1c (HbA1c) is a form of hemoglobin that is bound to glucose. The HbA1c test provides the patient with the average level of blood sugar only for the past 2 to 3 months.
HbA1c is a modified form of hemoglobin that is present in red blood cells. Most of the hemoglobin is in HbA form and during their lifespan, only a small fraction transforms into HbA1. HbA1 is further separated into HbA1a, HbA1b, and HbA1c. A high level of HbA1c is present in the body of diabetes patients as its formation occurs only during a process called glycosylation that converts glucose into glycogen for storage purposes. This HbA1c test results in the blood sugar level of the past 2 to 3 months of the diabetes patient’s body.
Worldwide, diabetes is one of the most prevalent epidemics and there are three types of diabetes. Out of them, type 2 diabetes is the common type. In September 2016, according to the National Center for Biotechnology Information (NCBI) research, diabetes is expected to be the seventh leading cause of death by the year 2030. In 2017, according to the report of the International Diabetes Federation, there are 12,465,800 diabetes cases are reported globally and the prevalence of diabetes in Brazil was 8.7% among adults. Due to these increasing occurrences, various testing methods like HbA1c testing equipment are diagnosed to the patients. This is the major driving factor of the HbA1c testing market growth.
The COVID-19 pandemic affects millions of people and brought the world to a standstill. Diabetic people and the HbA1c testing market are also impacted by this pandemic. This testing volume was decreased by 66% in March and April 2020. Due to the pandemic, the stay at home orders and social distancing regulations are imposed and thus results in decrement of HbA1c testing volumes convert to postponed testing’s and decline in HbA1c testing frequency. Moreover, in this way or any other reasons, the missing of HbA1c point of care testing leads to adverse impacts of glucose control, clinical outcomes, and diabetes-related medical prices. In this way, the HbA1c testing procedures are impacted by COVID-19 and decline its market growth. Further, post-COVID, the HbA1c testing market is rapidly increased due to its increased usage.
Rising per capita disposable income and developing healthcare infrastructure is the major driving factor for the growth of the market. Introducing advanced innovations in treatment options is propelling the growth of the market. Due to poor dietary choices, lack of physical activities, and higher stress levels, the people affected with diabetes are increasing day by day and the physicians are prescribing the HbA1c test fasting to their patients which increases the growth of the HbA1c testing market.
Additionally, the emergence of point of care and other latest innovations that reducing diabetes testing costs is aiding the HbA1c testing market growth. The continuous rise in the geriatric population leads to rising in diabetes patients all over the world. The rising scope of medical tourism in developing countries is boosting the HbA1c testing equipment market.
The testing devices are expensive. In few developing countries, these technologies are less adopted and are limiting the growth of the hemoglobin A1c testing devices market.
Rising adoption of advanced diagnostic tools and devices along with strategic activities like partnerships, and agreements among the prominent key players may create the opportunity to increase the market growth. The emergence of the latest testing procedures and advanced technologies like handheld devices is predicted to provide a lucrative opportunity for the HbA1c testing market growth. The rising awareness among the people regarding the management of diabetes efficiently is offering the growth of the market.
Manufacturing of these testing devices is cost high which poses a challenge for the market growth. Due to the discrepancies in interpretations, the HbA1c standard range testing result may be inaccurate which is hindering the HbA1c assay market growth.
Study Objectives -
The global HbA1c testing market has been divided into segments based on technology, product, end-user, and region.
Based on Technology
Based on the technology, the global hemoglobin testing market is classified into few types as ion-exchange HPLC, TINIA, enzymatic assay, and others. Out of these, ion-exchange HPLC is holding the largest market share for its high demand in the market. It is the most widely used testing kit that consumes less time, recognizes variants, and is also used in point-of-care settings. TINIA is expected to grow at a significant rate during the review period which offers the benefits like accurate results, cost-effectiveness, and quick-swiftness.
Based on Product
The global HbA1c testing machine market based on the product is bifurcated into two types as reagents & kits, and instruments. Further, the instruments are divided into a bench-top device and a handheld device.
Based on End-user
By end-user, the global HbA1c testing equipment market is analyzed into hospitals &clinics, diagnostic laboratories, and others. The hospitals &clinics segment is dominating the HbA1c testing market share due to the growing geriatric population worldwide.
Based on Region
Regionally, the global Hemoglobin testing machine market is categorized into four main geographies such as Europe, Asia-Pacific, America, and the Middle East & Africa. America is dominating the largest market share for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in emerging countries like the US and Canada.
Regional Analysis -
Geographically, the HbA1c testing global market is divided into four major regions like Asia-Pacific, Europe, America, and the Middle East & Africa. Out of these regions, America is holding the leading position in the HbA1c testing market for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in the US and Canada. Europe is predicted to hold the second-largest market share for their increasing adoption of advanced diagnostic tools and devices coupled with strategic activities like partnerships and agreements by the major key players is accelerating the market growth in this region.
Due to the developing healthcare infrastructure and increasing per capita disposable income, Asia-Pacific is witnessing the fastest-growing region. Due to limited access to healthcare, growing awareness regarding healthcare, and availability of the latest treatments, the Middle East & Africa is witnessing steady growth.
The prominent key players in the HbA1c testing market outlook are the following:
In January 2019, the most popular enterpriser EKF Diagnostics has introduced the world’s fastest hemoglobin analyzer DiaSpect Tm Hb in the US. It is used for the diagnosis of various disorders and increases the revenue of the company.
In December 2018, one of the top key players Siemens Healthineers announced the acquisition of Fast-Track Diagnostics (FTD) which is a global supplier of molecular diagnostic test kits. This acquisition improves patient experience and develops precision medicine.
In June 2017, the most famous vendor ARKRAY, Inc. decided to acquire HDK Philippines Inc. to establish ARKRAY Industry West, Inc. in the country that helps the company expansion for its operations in the Philippines.
This HbA1c testing global market research includes the Market Overview, COVID-19 analysis, Market Dynamics, Study Objectives, Segment Overview, Regional Analysis, Competitive Landscape, Recent developments, Segmentation Table, and FAQs. The market scenario includes the HbA1c testing market drivers, restraints, challenges, and opportunities. The HbA1c Testing market forecast segments are technology, product, end-user, and region.
Globally, the HbA1c Testing market trends have been segmented into four types based on the technology, product, end-user, and region.
Ion-exchange HPLC, TINIA, enzymatic assay, and others.
Reagents & kits, and instruments.
Hospitals &clinics, diagnostic laboratories, and others.
Asia-Pacific, Europe, North America, and the rest of the world are the four main geographies included in the HbA1c testing market.
|Market Size||USD 3229.3 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Technology and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India)|
|Key Market Opportunities||Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players|
|Key Market Drivers||
HbA1c Testing Market is projected to grow at a 12.9% CAGR between 2022-2030.
The Americas is expected to dominate the HbA1c Testing Market.
HbA1c Testing Market is predicted to touch USD 3229.3 Million by 2030.
The hospitals and clinics segment will lead the HbA1c Testing Market.
The reagents & kits segment will dominate the HbA1c Testing Market.